Global Access Strategy Lead, Cardiovascular
Company: Initial Therapeutics, Inc.
Location: Washington
Posted on: June 2, 2025
|
|
Job Description:
Join Amgen's Mission of Serving PatientsAt Amgen, if you feel
like you're part of something bigger, it's because you are. Our
shared mission to serve patients living with serious illnesses
drives all that we do.Since 1980, we've helped pioneer the world of
biotech in our fight against the world's toughest diseases. With
our focus on four therapeutic areas: Oncology, Inflammation,
General Medicine, and Rare Disease, we reach millions of patients
each year. As a member of the Amgen team, you'll help make a
lasting impact on the lives of patients as we research,
manufacture, and deliver innovative medicines to help people live
longer, fuller, happier lives.Our award-winning culture is
collaborative, innovative, and science-based. If you have a passion
for challenges and the opportunities that lay within them, you'll
thrive as part of the Amgen team. Join us and transform the lives
of patients while transforming your career.Global Access Strategy
Lead, CardiovascularWhat you will doLet's do this. Let's change the
world! In the context of a rapidly evolving payer environment,
Amgen's emphasis on geographic expansion, and a commitment to
demonstrate product value, Amgen requires an increasingly
sophisticated reimbursement and pricing capability to support
market access strategies (an important source for competitive
advantage).The Global Integrated Access Strategy team, within the
Global Value Access (GV&A) function, is a team committed to
excellence in this capability in order to position Amgen for
continued success. This global team is responsible for strategic
planning of value and access for all Amgen molecules in
development, beginning in Phase I-II and extending throughout
commercialization across the Amgen portfolio. This work also
includes lifecycle planning and access support for our inline
products. Additionally, the team is responsible for global
strategic pricing, including recommendations for global price
policies and launch sequence, and delivering on above-brand
initiatives to build our strategic capabilities.In this vital role,
the Director will serve as the Global Access Strategy Lead (ASL)
for Olpasiran, a molecule being developed for the treatment of
elevated Lp(a) in patients at risk of cardiovascular events, and
will represent payers' needs and perspectives on the
multi-disciplinary Product Team (PT).They will also lead and
coordinate the cross-functional efforts within Global Value Access
(GV&A) in order to support the access planning process,
including the situation analysis, creation of access strategies,
identification of critical success factors, development of pricing
guidance, and maintenance of price policy. The individual will also
collaborate with the PT to reflect payer-value drivers in the
assessment and design of the Olpasiran LCM pivotal trials and key
evidence generation projects. This opportunity will involve
significant interaction with top 10 markets and sub-regions to lead
access launch readiness and execution of the global access
strategy. The individual will be responsible for pricing and access
assumptions in global revenue forecasts for select products. The
Director must also oversee and conduct relevant payer/pricing
market research and Value Evidence Generation (with HEOR) and
integrate clinical, market, and payer information to develop and
communicate the access plan.Each ASL will work collaboratively
across functions to ensure a comprehensive view of their assigned
products and create and maintain strong working relationships with
key stakeholders. These individuals include global colleagues in
marketing, development, HEOR, regulatory, operations, advocacy, and
government affairs as well as key markets and regional VA
colleagues within the US, Europe, Canada,
Japan/Asia-Pacific/Australia, and other markets.In addition to
product-specific responsibilities, each member of the team also
participates in cross-portfolio projects each year. These projects
either serve to advance the department's knowledge of and readiness
for the global access environment, support specific market or
product assessments, or attempt to shape access policy
development.What we expect of youWe are all different, yet we all
use our unique contributions to serve patients. The professional we
seek is a strategic leader with these qualifications.Basic
Qualifications:Doctorate degree and 4 years of market access and/or
payer experienceOrMasters degree and 8 years of market access
and/or payer experienceOrBachelors degree and 9 years of market
access and/or payer experiencePreferred Qualifications:
#J-18808-Ljbffr
Keywords: Initial Therapeutics, Inc., Lancaster , Global Access Strategy Lead, Cardiovascular, Other , Washington, Pennsylvania
Click
here to apply!
|